Anti-mouse Ly6G-InVivo

Catalog No.A2158        Batch: A215811

       Clone No.1A8

Print

Anti-mouse Ly6G-InVivo reacts with mouse Ly6G. Ly6G is a 21-25 kDa member of the Ly-6 superfamily of GPI-anchored cell surface proteins with roles in cell signaling and cell adhesion.

Technical Data

Formulation PBS, pH 7.0 Contains no stabilizers or preservatives
Clone 1A8
Isotype Rat IgG2a, κ
Application Anti-mouse Ly6G-InVivo
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Sterility 5.86 mg/ml
Purity 99%
Protein concentration 5.86 mg/ml
Endotoxin Level ＜1EU/mg

Customer Product Validation

Verified customer review of Anti-mouse Ly6G-InVivo

Verified customer review of Anti-mouse Ly6G-InVivo

Selleck's Anti-mouse Ly6G-InVivo Has Been Cited by 12 publications

CCL3 + Neutrophil Signature Predicts Response to Neoadjuvant Toripalimab plus Chemotherapy in Patients with Hypopharyngeal Squamous Cell Carcinoma: A Phase II Trial [ Clinical Cancer Research, March 2026, nan]

https://www.ncbi.nlm.nih.gov/pubmed/?term=41817286
The IL-17A/Neutrophil axis plays a critical role in lethal infection induced by an emerging ultra-virulent Streptococcus suis serotype 5 strain [ Virulence, June 21, 2026, 2690810]
Neutrophil–Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension [ Advanced Science, June 10, 2025, e04397]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40492585
Neutrophil extracellular traps drive local tumor progression and metastasis following thermal ablation in liver cancer via TLR9-mediated inflammatory feedback and immunosuppression [ Journal for ImmunoTherapy of Cancer, July 07, 2026, e014851]

https://www.ncbi.nlm.nih.gov/pubmed/?term=42413984
Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduct Target Ther, 2025, 10(1):161]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40374605
Tumour-resident oncolytic bacteria trigger potent anticancer effects through selective intratumoural thrombosis and necrosis [ Nat Biomed Eng, 2025, 10.1038/s41551-025-01459-9]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40764397
Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy [ Cell Rep Med, 2025, 6(11):102434]

https://www.ncbi.nlm.nih.gov/pubmed/?term=41197618
Systemic administration of Photobacterium angustum promotes antitumor immunity and direct tumor lysis in murine models of colorectal cancer [ J Immunother Cancer, 2025, 13(11)e012665]

https://www.ncbi.nlm.nih.gov/pubmed/?term=41260901
Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target [ Cell Rep, 2025, 44(5):115631]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40279244
The C-type lectin receptor Dcir (Clec4a2) restrains Aspergillus fumigatus elimination by limiting the degranulatory activity of neutrophils [ Front Immunol, 2025, 16:1639400]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40831560

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.